argenx SE | ARGX - Ebitda

Prix De L'Action
671.20
Variation Quotidienne
-17.20 -2.50%
Mensuellement
0.09%
Annuel
38.02%
Q2 Prévisions
653.64




Ebitda Changement Date
AstraZeneca USD 5.67B 1.29B 2026-03
Galapagos EUR 560.5M 558.08M 2025-12
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Qiagen NV USD 249.69M 56.53M 2025-12
UCB EUR 1.6B 570M 2025-12